Haemonetics Corporation (NYSE:HAE) reported upbeat earnings for its third quarter on Thursday.
The company posted quarterly earnings of $1.31 per share which beat the analyst consensus estimate of $1.25 per share. The company reported quarterly sales of $338.967 million which beat the analyst consensus estimate of $331.616 million.
Haemonetics raised its FY2026 adjusted EPS guidance from $4.80-$5.00 to $4.90-$5.00.
Haemonetics shares fell 6% to trade at $61.13 on Friday.
These analysts made changes to their price targets on Haemonetics following earnings announcement.
- Barrington Research …